Patents by Inventor James Provost

James Provost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR THE DELIVERY OF SUBSTITUTED NAPTHYL INDOLE DERIVATIVES AND METHODS OF THEIR USE
    Publication number: 20070185186
    Abstract: This invention relates to compositions for the delivery of substituted naphthyl indole derivatives as well as to the use of these compositions and methods for treating disease.
    Type: Application
    Filed: January 31, 2007
    Publication date: August 9, 2007
    Applicant: Wyeth
    Inventors: Behnam Abdolalizadeh, T. Armstrong, James Provost, Zerina Shafi, M. Ku
  • Novel succinate salt of O-desmethyl-venlafaxine
    Publication number: 20070037884
    Abstract: A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.
    Type: Application
    Filed: January 18, 2006
    Publication date: February 15, 2007
    Applicant: Wyeth
    Inventors: Anthony Hadfield, Syed Shah, James Provost
  • Formulations of substituted benzoxazoles
    Publication number: 20060121110
    Abstract: The present invention relates to solid dosage formulations that include ER?-selective ligands that contain benzoxazole, and processes for manufacture of said formulations, more particularly to novel formulations and processes for manufacture of formulations containing the ER?-selective ligand, ERB-041.
    Type: Application
    Filed: November 30, 2005
    Publication date: June 8, 2006
    Applicant: Wyeth
    Inventors: James Provost, Trevor Armstrong, Zerina Shafi, Marc Tesconi, Mannching Ku
  • Extended release pharmaceutical dosage form
    Publication number: 20050129762
    Abstract: This invention relates to novel extended release pharmaceutical dosage forms for orally delivering drugs to mammals, e.g., humans. More particularly, this invention concerns novel dosage forms of water soluble drugs such as venlafaxine, enantiomeric (R or S) forms of venlafaxine, metabolites of venlafaxine such as O-desmethyl venlafaxine (ODV) or enantiomeric (R or S) forms of said metabolites which dosage forms have an extended release profile when taken orally. This invention also provides processes for preparing such dosage forms and methods of using them.
    Type: Application
    Filed: October 13, 2004
    Publication date: June 16, 2005
    Applicant: Wyeth
    Inventors: Nicholas Heaton, Angela Potts, Ian Armstrong, James Provost
  • Novel succinate salt of O-desmethyl-venlafaxine
    Publication number: 20050096479
    Abstract: A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.
    Type: Application
    Filed: November 10, 2004
    Publication date: May 5, 2005
    Applicant: Wyeth
    Inventors: Anthony Hadfield, Syed Shah, Michael Winkley, Karen Sutherland, James Provost, Aeri Park, Rex Shipplett, Brenton Russell, Beat Weber
  • Differential current thermal mass flow transducer
    Patent number: 5461913
    Abstract: The disclosed mass flow transducer is of the type including a balanced bridge comprising two, substantially identical, thermal elements forming two sides of the bridge between the top and the bottom of the bridge, the two elements being adapted to be positioned in two regions of a laminar flow tube in a symmetrical tandem arrangement so as to sense flow through the tube, one element being upstream from the other. The preferred transducer includes control means for monitoring the voltage at the top and bottom of the bridge and monitoring the current required to maintain the node between the thermal elements at virtual ground.
    Type: Grant
    Filed: June 23, 1994
    Date of Patent: October 31, 1995
    Assignee: MKS Instruments, Inc.
    Inventors: Luke D. Hinkle, James Provost